Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability - PubMed (original) (raw)
. 1999 Mar 1;59(5):1090-5.
M Esteller, S Wang, G Tamura, H Suzuki, J Yin, T T Zou, J M Abraham, D Kong, K N Smolinski, Y Q Shi, M G Rhyu, S M Powell, S P James, K T Wilson, J G Herman, S J Meltzer
Affiliations
- PMID: 10070967
Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability
A S Fleisher et al. Cancer Res. 1999.
Abstract
Human gastric carcinoma shows a higher prevalence of microsatellite instability (MSI) than does any other type of sporadic human cancer. The reasons for this high frequency of MSI are not yet known. In contrast to endometrial and colorectal carcinoma, mutations of the DNA mismatch repair (MMR) genes hMLH1 or hMSH2 have not been described in gastric carcinoma. However, hypermethylation of the hMLH1 MMR gene promoter is quite common in MSI-positive endometrial and colorectal cancers. This hypermethylation has been associated with hMLH1 transcriptional blockade, which is reversible with demethylation, suggesting that an epigenetic mechanism underlies hMLH1 gene inactivation and MMR deficiency. Therefore, we studied the prevalence of hMLH1 promoter hypermethylation in a total of 65 gastric tumors: 18 with frequent MSI (MSI-H), 8 with infrequent MSI (MSI-L), and 39 that were MSI negative. We found a striking association between hMLH1 promoter hypermethylation and MSI; of 18 MSI-H tumors, 14 (77.8%) showed hypermethylation, whereas 6 of 8 MSI-L tumors (75%) were hypermethylated at hMLH1. In contrast, only 1 of 39 (2.6%) MSI-negative tumors demonstrated hMLH1 hypermethylation (P<0.0001 for MSI-H or MSI-L versus MSI-negative). Moreover, hypermethylated cancers demonstrated diminished expression of hMLH1 protein by both immunohistochemistry and Western blotting, whereas nonhypermethylated tumors expressed abundant hMLH1 protein. These data indicate that hypermethylation of hMLH1 is strongly associated with MSI in gastric cancers and suggest an epigenetic mechanism by which defective MMR occurs in this group of cancers.
Similar articles
- Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype.
Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Endoh Y, et al. Am J Pathol. 2000 Sep;157(3):717-22. doi: 10.1016/S0002-9440(10)64584-1. Am J Pathol. 2000. PMID: 10980110 Free PMC article. - Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia.
Fleisher AS, Esteller M, Tamura G, Rashid A, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Nishizuka S, James SP, Wilson KT, Herman JG, Meltzer SJ. Fleisher AS, et al. Oncogene. 2001 Jan 18;20(3):329-35. doi: 10.1038/sj.onc.1204104. Oncogene. 2001. PMID: 11313962 - Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.
Fleisher AS, Esteller M, Harpaz N, Leytin A, Rashid A, Xu Y, Liang J, Stine OC, Yin J, Zou TT, Abraham JM, Kong D, Wilson KT, James SP, Herman JG, Meltzer SJ. Fleisher AS, et al. Cancer Res. 2000 Sep 1;60(17):4864-8. Cancer Res. 2000. PMID: 10987299 - Epigenetics, mismatch repair genes and colorectal cancer.
Wheeler JM. Wheeler JM. Ann R Coll Surg Engl. 2005 Jan;87(1):15-20. doi: 10.1308/1478708051423. Ann R Coll Surg Engl. 2005. PMID: 15720901 Free PMC article. Review. - Microsatellite instability as a tool for the classification of gastric cancer.
Simpson AJ, Caballero OL, Pena SD. Simpson AJ, et al. Trends Mol Med. 2001 Feb;7(2):76-80. doi: 10.1016/s1471-4914(01)01916-5. Trends Mol Med. 2001. PMID: 11286759 Review.
Cited by
- Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype.
Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T. Endoh Y, et al. Am J Pathol. 2000 Sep;157(3):717-22. doi: 10.1016/S0002-9440(10)64584-1. Am J Pathol. 2000. PMID: 10980110 Free PMC article. - Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet, Kazmi HR, Kumari S, Tiwari S, Khanna A, Narayan G. Puneet, et al. Pathol Oncol Res. 2018 Oct;24(4):757-770. doi: 10.1007/s12253-018-0410-z. Epub 2018 Mar 19. Pathol Oncol Res. 2018. PMID: 29552712 Review. - The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer.
Koga Y, Kitajima Y, Miyoshi A, Sato K, Sato S, Miyazaki K. Koga Y, et al. J Gastroenterol. 2006 Feb;41(2):133-9. doi: 10.1007/s00535-005-1732-7. J Gastroenterol. 2006. PMID: 16568372 - Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability.
Baek MJ, Kang H, Kim SE, Park JH, Lee JS, Paik YK, Kim H. Baek MJ, et al. Br J Cancer. 2001 Oct 19;85(8):1147-52. doi: 10.1054/bjoc.2001.2051. Br J Cancer. 2001. PMID: 11710827 Free PMC article. - Geno- and pheno-typic characterization in ten patients with double-primary gastric and colorectal adenocarcinomas.
Kim JC, Koo KH, Kim HC, Kim JS, Kang GH. Kim JC, et al. Int J Colorectal Dis. 2004 Nov;19(6):561-8. doi: 10.1007/s00384-004-0591-7. Epub 2004 Apr 9. Int J Colorectal Dis. 2004. PMID: 15083323
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical